Lilly and Amgen partner to manufacture potential coronavirus drugs


Lilly corporate headquarters in Indianapolis, Indiana

Source: Eli Lilly

Eli Lilly on Thursday partnered with Amgen to increase the supply of its experimental Covid-19 antibody treatments, a day after one of Lilly’s drugs was shown to reduce the need for hospitalization.

Through the collaboration, the companies will have the ability to scale up production should one or more of Lilly’s antibody therapies receive regulatory approval, the companies said in a statement.

Antibody treatments work by recognizing and locking onto foreign invaders to prevent infection of healthy cells. Several companies including Regeneron Pharmaceuticals and Vir Biotechnology are also testing antibody treatments for Covid-19.

Eli Lilly on Wednesday reported that a single infusion of its experimental antibody treatment cut hospitalizations and emergency room visits for clinical trial patients with moderate Covid-19.

“We are impressed with Lilly’s data, in particular the reduction in hospitalizations, and are enthusiastic about the potential for these neutralizing antibodies as a therapeutic for Covid-19,” David Reese, Amgen’s research and development chief, said in the statement.

Eli Lilly said on Wednesday it would discuss the interim data with global regulators, including the U.S. Food and Drug Administration, and that discussions could also include the possibility of an emergency use authorization.

Amgen has been studying its own psoriasis drug, Otezla, as a potential treatment for Covid-19. It also has a separate partnership with Adaptive Biotechnologies to develop antibody drugs to potentially prevent or treat Covid-19.



Source link

Discover

Sponsor

Latest

PM Boris Johnson outlines more measures

A couple wearing protective face coverings chat in the street in Liverpool city centre, north-west England on September 18, 2020.OLI SCARFF | AFP...

Financial advisory industry seeks to overcome lack of racial diversity

Martin Seay of FPASource: Financial Planning AssociationMartin Seay's term as president of the Financial Planning Association has, to say the least, been an...

Must be a ‘global public good,’ WHO says

A health care worker injects the a syringe of the phase 3 vaccine trial, to a volunteer at the Ankara University Ibni Sina...

Ultra-cold freezer maker sees surge in demand to store Covid vaccines

Vials of coronavirus disease (COVID-19) vaccine candidate BNT162b2 are sorted at a Pfizer facility in Puurs, Belgium in an undated still image from...

McDonald’s (MCD) Q4 2020 earnings

People wear protective face masks outside McDonald's in Times Square as the city continues Phase 4 of re-opening following restrictions imposed to slow...